SKIN TOXICITY IN PATIENTS ON CHECKPOINT INHIBITORS

Clinical trials for SKIN TOXICITY IN PATIENTS ON CHECKPOINT INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SKIN TOXICITY IN PATIENTS ON CHECKPOINT INHIBITORS trials appear

Sign up with your email to follow new studies for SKIN TOXICITY IN PATIENTS ON CHECKPOINT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Simple skin creams could ease cancer Treatment's itchy side effect

Symptom relief Completed

This study tested whether over-the-counter skin care products could prevent or reduce itchy skin rashes caused by immunotherapy in cancer patients. 130 adults starting immunotherapy for solid tumors were randomly assigned to use either a special cream containing niacinamide and s…

Matched conditions: SKIN TOXICITY IN PATIENTS ON CHECKPOINT INHIBITORS

Phase: NA • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Symptom relief

Last updated Mar 17, 2026 13:10 UTC

SKIN TOXICITY IN PATIENTS ON CHECKPOINT INHIBITORS

Get alerted when new SKIN TOXICITY IN PATIENTS ON CHECKPOINT INHIBITORS trials appear

Simple skin creams could ease cancer Treatment's itchy side effect